SCHEMBL18767289

SCHEMBL18767289

C/N=C\c1cccc(C(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
NPC1 O15118 3/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KIF11 P52732 1/20 0.39
ACHE P22303 3/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CHRM5 P08912 3/20 0.36
NFE2L2 Q16236 1/20 0.36
ASIC1 P78348 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8274381 0.82 MAPT (0.51) HDAC4HDAC2HDAC8NPC1CASP3
SCHEMBL29942690 0.82 HDAC4 (0.39) HDAC4HDAC2HDAC8NPC1CASP3
SCHEMBL14088919 0.82 MAPT (0.51) HDAC4HDAC2HDAC8NPC1CASP3
SCHEMBL23752855 0.82 HDAC4 (0.39) HDAC4HDAC2HDAC8NPC1CASP3
SCHEMBL14904519 0.82 NFE2L2 (0.54) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL23752854 0.82 HDAC4 (0.39) HDAC4HDAC2HDAC8NPC1CASP3
SCHEMBL13459745 0.80 NPC1 (0.50) NPC1CASP3SENP8SENP7SENP6
SCHEMBL8274382 0.79 SRC (0.47) HDAC4HDAC2HDAC8NPC1CASP3
SCHEMBL5433181 0.79 HDAC8 (0.45) HDAC4HDAC2HDAC8NPC1CASP3
SCHEMBL349422 0.77 HDAC8 (0.44) HDAC4HDAC2HDAC8NPC1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017066742-A1 BACE-2 INHIBITORY COMPOUNDS AND RELATED METHODS OF USE JORTAN PHARMACEUTICALS INC. (US) 2017-04-20 WO disclosed